Panacea Biotec Ltd
NSE:PANACEABIO
Panacea Biotec Ltd
NSE:PANACEABIO
Price:
328.25
INR
1.93%
Market Closed
Market Cap:
₹20.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
IN |
|
Elma Electronic AG
SIX:ELMN
|
CH |
|
X
|
XiAn Peri Power Semiconductor Converting Technology Co Ltd
SZSE:300831
|
CN |
|
M
|
Medmen Enterprises Inc
CNSX:MMEN
|
US |
|
H
|
Hainan Haiqi Transportation Group Co Ltd
SSE:603069
|
CN |
|
Vantage Towers AG
XETRA:VTWR
|
DE |
|
Comefly Outdoor Co Ltd
SSE:603908
|
CN |
|
V
|
Vintage Coffee and Beverages Ltd
BSE:538920
|
IN |
|
LFTD Partners Inc
OTC:LIFD
|
US |
Relative Value
The Relative Value of one
PANACEABIO
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 328.25 INR,
Panacea Biotec Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PANACEABIO Relative Value
HIDDEN
Multiples Across Competitors
PANACEABIO Competitors Multiples
Panacea Biotec Ltd Competitors
Panacea Biotec Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
20.1B INR | 3.3 | -258.4 | -56.7 | -28.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD | 5.9 | 86.7 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD | 9.5 | 28.8 | 21.7 | 22.6 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD | 5.5 | 17.4 | 12.8 | 14.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
35.7B EUR | 10.3 | 33 | 35.6 | 36.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
